{"id":263961,"date":"2024-05-10T00:00:00","date_gmt":"2024-05-10T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/products\/research-reports\/report\/exinop0005-2024-biopharma-dry-eye-executive-insights-dry-eye-disease\/"},"modified":"2026-03-31T10:30:10","modified_gmt":"2026-03-31T10:30:10","slug":"exinop0005-2024-biopharma-dry-eye-executive-insights-dry-eye-disease-executive-insights-us","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/exinop0005-2024-biopharma-dry-eye-executive-insights-dry-eye-disease-executive-insights-us\/","title":{"rendered":"Dry Eye &#8211; Executive Insights &#8211; Dry eye disease | Executive Insights (US)"},"content":{"rendered":"","protected":false},"template":"","class_list":["post-263961","report","type-report","status-publish","hentry","report-gateway-biopharma","biopharma-therapy-areas-dry-eye","biopharma-therapy-areas-ophthalmology","biopharma-geography-us","biopharma-date-985"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/263961","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/263961\/revisions"}],"predecessor-version":[{"id":281011,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/263961\/revisions\/281011"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=263961"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}